1. Epigenetic Biomarkers in Personalized Medicine
    Fabio Coppedè et al, 2015, Personalized Epigenetics CrossRef
  2. Dietary fat and obesity as modulators of breast cancer risk: Focus on DNA methylation
    Micah G. Donovan et al, 2020, British Journal of Pharmacology CrossRef
  3. RASSF1A: A promising target for the diagnosis and treatment of cancer
    Yuling Bin et al, 2020, Clinica Chimica Acta CrossRef
  4. Novel strategy for activating gene expression through triplex DNA formation targeting epigenetically suppressed genes
    Ryotaro Notomi et al, 2024, RSC Chemical Biology CrossRef
  5. Aberrant DNA Methylation in Breast Cancer Cells
    Emanuel Martín Campoy et al, 2013, Medical Epigenetics CrossRef
  6. Epigenetic epidemiology of cancer
    Timothy M. Barrow et al, 2014, Biochemical and Biophysical Research Communications CrossRef
  7. Epigenetic mechanisms of importance for drug treatment
    Maxim Ivanov et al, 2014, Trends in Pharmacological Sciences CrossRef
  8. RAD6 inhibition enhances paclitaxel sensitivity of triple negative breast cancer cells by aggravating mitotic spindle damage
    Brittany M. Haynes et al, 2022, BMC Cancer CrossRef
  9. Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker
    Mersedeh Rohanizadegan, 2018, Cancer Genetics CrossRef
  10. Epigenetic biomarkers in personalized medicine
    Andrea Stoccoro et al, 2024, Personalized Epigenetics CrossRef
  11. Methylation-mediated gene silencing as biomarkers of gastric cancer: A review
    Jun Nakamura, 2014, World Journal of Gastroenterology CrossRef
  12. Gene Methylation in Circulating Cell-Free DNA from the Blood Plasma as Prognostic and Predictive Factor in Breast Cancer
    S. V. Rykov et al, 2021, Russian Journal of Genetics CrossRef
  13. Secreted Frizzled Related Protein 1 Modulates Taxane Resistance of Human Lung Adenocarcinoma
    Jin Ren et al, 2014, Molecular Medicine CrossRef
  14. Detection of aberrant methylation of tumor suppressor genes in plasma from cancer patients
    Hiroaki Kawasaki et al, 2013, Personalized Medicine Universe CrossRef
  15. HIC1 and RassF1A Methylation Attenuates Tubulin Expression and Cell Stiffness in Cancer
    Chih-Cheng Chen et al, 2018, International Journal of Molecular Sciences CrossRef
  16. Epigenetic alternations and cancer chemotherapy response
    Jin-Feng Lv et al, 2016, Cancer Chemotherapy and Pharmacology CrossRef
  17. CpG site-specific RASSF1a hypermethylation is associated with occupational PAH exposure and genomic instability
    Zhini He et al, 2015, Toxicology Research CrossRef